Diagnosis and management of insomnia. [N Engl J Med. 1990] - PubMed

loading

[Halcion (triazolam) in the treatment of insomnia]. [Ter Arkh. 1997]
[Halcion (triazolam) in the treatment of insomnia].
Muzychenko AP, Prokudin VN, Bogdan AN. Ter Arkh. 1997; 69(1):65-8.
Triazolam--a new benzodiazepine for insomnia. [Med Lett Drugs Ther. 1983]
Triazolam--a new benzodiazepine for insomnia.
. Med Lett Drugs Ther. 1983 Mar 18; 25(631):32.
Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation. [Psychopharmacology (Berl). 1992]
Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation.
Roehrs T, Merlotti L, Zorick F, Roth T. Psychopharmacology (Berl). 1992; 108(1-2):67-71.
Review Insomnia and the new benzodiazepines. [Clin Pharm. 1982]
Review Insomnia and the new benzodiazepines.
Wincor MZ. Clin Pharm. 1982 Sep-Oct; 1(5):425-32.
Review Rebound insomnia: a critical review. [J Clin Psychopharmacol. 1989]
Review Rebound insomnia: a critical review.
Gillin JC, Spinweber CL, Johnson LC. J Clin Psychopharmacol. 1989 Jun; 9(3):161-72.

Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields. [Br J Cancer. 2011]
Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.
Costa FP, de Oliveira AC, Meirelles R, Machado MC, Zanesco T, Surjan R, Chammas MC, de Souza Rocha M, Morgan D, Cantor A, et al. Br J Cancer. 2011 Aug 23; 105(5):640-8. Epub 2011 Aug 9.
Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. [J Exp Clin Cancer Res. 2009]
Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach.
Barbault A, Costa FP, Bottger B, Munden RF, Bomholt F, Kuster N, Pasche B. J Exp Clin Cancer Res. 2009 Apr 14; 28:51. Epub 2009 Apr 14.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Diagnosis and management of insomnia.
Diagnosis and management of insomnia.
N Engl J Med. 1990 Aug 16 ;323(7):486-7.

PubMed
MgCl2-sensitive and Gpp(NH)p-sensitive antagonist binding states of rat heart mu...
MgCl2-sensitive and Gpp(NH)p-sensitive antagonist binding states of rat heart muscarinic receptors: preferential detection at ambient temperature assay and location in two subcellular fractions.
Mol Cell Biochem. 1990 May 10 ;94(2):133-46.

PubMed
Acute lymphoblastic leukemia with eosinophilia.
Acute lymphoblastic leukemia with eosinophilia.
Medicine (Baltimore). 1990 Jul ;69(4):232-43.

PubMed
Long-term effects of dieting on resting metabolic rate in obese outpatients.
Long-term effects of dieting on resting metabolic rate in obese outpatients.
JAMA. 1990 Aug 8 ;264(6):707-11.

PubMed
In line final filters for removing particles from amphotericin B infusions.
In line final filters for removing particles from amphotericin B infusions.
Am J Hosp Pharm. 1975 Feb ;32(2):173-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed